The leadless pacemaker in wireless communication with a subcutaneous ICD exceeded performance goals for freedom from major complications related to the leadless pacemaker, for communication ...

The S-ICD easily met the prespecified primary safety and efficacy endpoints: Primary safety end point (180-day complication-free rate): 99%. The lower confidence limit of 87.9% surpassed the ...

The FDA’s Circulatory System Devices panel voted 7-1 on Thursday that the benefits of the Cameron Health subcutaneous ICD system (S-ICD) outweigh the risks in appropriately selected patients.

FDA approves first subcutaneous ICD. Reed Miller. September 28, 2012. Silver Spring, MD - As expected, the S-ICD (Cameron Health/Boston Scientific) ...

A study, conducted by researchers at Population Health Research Institute (PHRI) has demonstrated that a new type of cardiac defibrillator called a subcutaneous ICD (S-ICD) reduced patient ...

Extraction of a subcutaneous implantable cardioverter defibrillator was safe and feasible and produced no complications, according to registry data presented at Heart Rhythm 2023.The researchers ...

HRS: iPad2 Can Trigger Magnet Mode in Defibrillators The subcutaneous implantable cardioverter-defibrillator (S-ICD System) is both safe and effective for the treatment of life-threatening ...

Medtronic’s recent FDA-approved Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) is poised to revolutionise the cardiac device market. This device, which places leads outside ...

FDA approves new subcutaneous ICD S-ICD is indicated for patients at risk of ventricular tachyarrhythmias who do not require a pacemaker or pacing therapy. HealthDay News — The FDA has approved ...

Early implementation of the subcutaneous implantable cardioverter defibrillator in the United States has been linked to low complication rates and increased rates of successful defibrillation ...